Switch to:
More From Other Websites
Merck cholesterol drug Vytorin faces competition from Impax, Teva generics Apr 26 2017
FDA approves Impax generic of Merck's cholesterol drug Vytorin Apr 26 2017
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin® (Ezetimibe/Simvastatin... Apr 26 2017
Vetr Crowd Urges Sell For Impax Laboratories Apr 24 2017
Impax to Present Data on Rytary® (Carbidopa and Levodopa) Extended-Release Capsules, Zomig®... Apr 21 2017
Blog Coverage AbbVie's HCV Regimen Achieves 99% Cure Rate in Phase III Study Apr 21 2017
Impac Secured Assets Corp. Mortgage Pass-Through Certificates, Series 2006-5 -- Moody's downgrades... Apr 13 2017
Impax to Report First Quarter 2017 Results on May 10, 2017 Apr 06 2017
Impax (IPXL) Up 35.3% Since Earnings Report: Can It Continue? Apr 04 2017
Impax Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray Mar 30 2017
Cellect Biotechnology and Impax Laboratories Post Solid Gains Mar 28 2017
Impax Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IPXL-US : March... Mar 28 2017
Why Impax Labs Soared 37.3% Today Mar 27 2017
Impax Gains 38% On CEO Appointment, Talk of Sale Mar 27 2017
Skincare Makers Lead Biotech Movers Mar 27 2017
Impax Board of Directors Appoints Paul M. Bisaro President and CEO Mar 27 2017
Falling Earnings Estimates Signal Weakness Ahead for Impax Laboratories (IPXL) Mar 22 2017
Impax Hires Morgan Stanley for Strategic Review, Possible Sale Mar 08 2017
Impax Laboratories, Inc. :IPXL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Mar 07 2017
New Strong Sell Stocks for March 6th Mar 06 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK